Findings showed pegvaliase reduced mean blood Phe levels from baseline by 49.7% compared with 0.3% with diet only at week 72.

Encaleret is an oral, small molecule designed to selectively modulate the calcium-sensing receptor protein to restore PTH secretion and calcium reabsorption.

Topline data were announced from 2 replicate phase 3 studies evaluating upadacitinib in adults and adolescents with nonsegmental vitiligo (NSV).

SARS-CoV-2 mRNA vaccination within 100 days of ICI initiation was associated with increased overall survival in patients with NSCLC or metastatic melanoma.

The decision came following a meeting with the FDA during which the Company and the Agency could not come to an agreement on the design of the VALOR clinical trial.

Ianalumab significantly reduced disease activity in patients with Sjögren disease, according to results presented at the American College of Rheumatology (ACR) Convergence 2025.

Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1% were SLN-positive.

Results of a systematic review and meta-analysis showed that LDN was safe and effective for reducing pain and improving functional outcomes in fibromyalgia.

From week 16, patients who were randomized to placebo were switched to deucravacitinib, while those who received deucravacitinib initially remained on treatment through week 52.

HealthDay News — A 67-year-old New Hampshire man has set a medical milestone after living more than nine months with a gene-edited pig kidney, doctors announced Monday. The experimental transplant, ...

Once inside his digestive tract, the magnets pulled sections of his bowel toward each other, causing severe internal damage ...

The new approval allows patients to transition to a single 200mg subcutaneous injection once every 4 weeks, following completion of the induction phase.